Navigation Links
The combination of monolithic columns and modern HPLC/MS/MS instrumentation for high chromatographic throughput and sensitive detection of beta-agonists

Beta-agonists are group A substances of the European guideline 93/257/EWG (revision 98/536/EG) having an anabolic effect and not licensed. Thus, they have to be determined in veterinarian samples like muscle, liver, retina, and urine. The coupling of High Pressure Liquid Chromatography (HPLC) and Electrospray Ionization Tandem Mass Spectrometry (ESI-MS-MS) seems to be the analytical method of choice for such thermally labile and polar substances. Classical HPLC/ESI-MS-MS instrumentation allows the determination with satisfying detection limits, accuracy, and reproducibility. Due to the high number of substances that have to be analyzed in a single run, longer chromatographic separation times have to be accepted. Monolithic columns are made of a single piece of porous silica with a defined pore structure. Thus, lower back pressure in the column allows the use of higher flow rates and flow gradients, without loss in chromatographic resolution. In the following work the possibility of increasing sample throughput and sensitivity using monolithic columns at higher flow rates and a modern mass spectrometer, which is optimized to work with such high flow rates is evaluated.

High Pressure Liquid Chromatography

: Agilent 1100 series binary pump, column oven, and well-plate autosampler

columns: Inertsil ODS-3 150x2.1 mm at a flow rate of 200 μL/min Merck Chromolith SpeedROD RP-18e 50x4.6 mm at flow rates of 1000 μL/min and 2000 μL/min

eluent A: H2O+5mM NH4formiate pH=4.0 eluent B: acetonitrile+5% H2O

gradients (A/B):

column oven temperature of 25C

injection of 20 μl Mass Spectrometry:

Applied Biosystems API 4000 LC/MS/MS System with Turbo V source in positive ion mode 500C at 200 μl/min 700C at 1000 and 2000 μl/min (without split)

detection of 46 MRMs in 3 periods using dwell times of 50-120 ms dependent on flow rate

2 to 3 internal standards were used in each period

Determination of group A substances

For doubtless determination of betaagonists, 4 identification points have to be achieved (guideline 93/256/EWG). That means in case of HPLC/MS/MS 2 MRMs (1 precursor ion and two product ions) have to be measured. The ratio of quantifier and qualifier MRM must be stable with a tolerance of 20 to 50% independent of relative intensity. Retention times must be higher than 2 times of the dead volume of the column and relative retention times are allowed to shift by 2.5%.

Results

By using monolithic columns at higher flow rates, the time for analysis can be reduced drastically (Figures 1-3). At flow rates below 1000 μL/min peak shape on this column is not satisfying (not shown). In the case of analysed -agonists the time of analysis dropped from 43 minutes to 15 minutes (1000 μL/min) or 8 minutes (2000 μL/min), respectively, including equilibration time (Figure 4). Due to optimised gas streams in the ion source and the possibilities of using higher temperatures for evaporation, similar or even lower limits of detection (LOD) were achieved for analyzed compounds at 1000 μL/min (Table). Little loss of sensitivity must be tolerated when flow rates of 2000 μL/min or higher are used. LODs of 1000 and 2000 μL/min are comparable when compounds elute with higher organic content due to easier evaporation of such solvents.


'"/>

Source:


Page: All 1 2

Related biology technology :

1. Generate Adenovirus Vectors in E. coli by Homologous Recombination with the AdEasy Adenoviral Vector System
2. HPLC/MS/MS Analysis of Bitter Acids in Hops and Beer
3. Determination of Polar Organophosphorus Pesticides in Aqueous Samples by Direct Injection Using HPLC/MS/MS
4. Detection of nitrofurane metabolites in food with HPLC/MS/MS
5. High-throughput gene expression analysis to screen for anti-asthma drugs
6. DirectPrep 96 Miniprep System for cost-effective, high-throughput plasmid DNA purification
7. Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000
8. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
9. A highly sensitive ATP-luminescence assay using VICTOR2 with the dispenser option
10. Monitoring transfection efficiency by green fluorescent protein (GFP) detection with the Agilent 2100 bioanalyzer
11. Apoptosis detection by annexin V and active caspase-3 with the Agilent 2100 bioanalyzer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... -- ATCC, the premier global biological materials resource and ... life science researchers that are working to address the ... CDC website . --> CDC website ... single-stranded RNA virus of the Flaviviridae family, genus Flavivirus, ... Viruses. Zika virus is transmitted to humans primarily through ...
(Date:2/5/2016)... , February 5, 2016 ... a biotechnology company focused on developing products for Regenerative ... requested Rare Pediatric Disease Designation (RPDD) from the US ... (RP) with MANF. MANF was previously granted orphan drug ... --> Amarantus BioScience Holdings, Inc. ...
(Date:2/4/2016)... February 4, 2016 - New FDA action date of ... New FDA action date of July 22, 2016 ... July 22, 2016   - Lifitegrast ... past decade indicated for the treatment of signs and symptoms of ... has the potential to be the only product approved in the U.S. in the past ...
(Date:2/4/2016)... , ... February 04, 2016 ... ... presented by Bloomsburg University’s Digital Forensics Club, takes place February 5-6 at ... event features 20+ speakers and activities such as workshops and competitions for ...
Breaking Biology Technology:
(Date:2/3/2016)... Feb. 3, 2016 ... of the "Emotion Detection and Recognition ... and Others), Software Tools (Facial Expression, Voice ... Users,and Regions - Global forecast to 2020" ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced the ...
(Date:2/2/2016)... , Feb. 2, 2016 Checkpoint ... that Rising Market Are you interested in ... forecasts revenues for checkpoint inhibitors. Visiongain,s report gives ... submarket, product and national level. Avoid falling ... what progress, opportunities and revenues those emerging cancer ...
(Date:2/2/2016)... Feb. 2, 2016  Based on its recent ... Sullivan recognizes US-based Intelligent Retinal Imaging Systems (IRIS) ... Award for New Product Innovation. IRIS, a prominent ... North America , is poised to set ... diabetic retinopathy market. The IRIS technology presents superior ...
Breaking Biology News(10 mins):